The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
25442308 |
16 |
Design, synthesis and molecular docking of substituted 3-hydrazinyl-3-oxo-propanamides as anti-tubercular agents.![EBI](/images/logo_chembl.png) |
Csir-Central Drug Research Institute |
22469702 |
36 |
Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis.![EBI](/images/logo_chembl.png) |
Mrc Technology |
22037378 |
31824 |
Comprehensive analysis of kinase inhibitor selectivity.![EBI](/images/logo_chembl.png) |
Ambit Biosciences |
29706526 |
1 |
Synthesis, antimycobacterial activity and influence on mycobacterial InhA and PknB of 12-membered cyclodepsipeptides.![EBI](/images/logo_chembl.png) |
Martin-Luther-Universit£T Halle-Wittenberg |
29259738 |
74 |
Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions.![EBI](/images/logo_chembl.png) |
Vertex Pharmaceuticals |